Selektory ogólne
Tylko dokładne dopasowania
Szukaj w tytule
Wyszukiwanie w treści

Kupuj akcje Glaxosmithkline

logo etoro

Minimalna wpłata
$50
Ekskluzywna promocja

Nasz wynik
★★★★★ 10/10

0% prowizja

kupić akcje glaxosmithkline

Are you looking to buy GlaxoSmithKline stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:GSK! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about GlaxoSmithKline stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Średnia wielkość

5.81 million shs

KAPITAŁ RYNKOWY

$88.55 billion

Giełda Papierów Wartościowych

NYSE

Proszę kupić te akcje!

NAZWA
TICKER
PRZEMYSŁ
SEKTOR
VOLUME
KUP TERAZ TĘ AKCJĘ
GlaxoSmithKline
NYSE:GSK
Preparaty farmaceutyczne
Medyczny
262,467 shs

How to buy GlaxoSmithKline stocks?

Below is a quick guide on how to buy NYSE:GSK stocks safe, fast and around the world in less than five minutes.

Krok 1: Otworzyć rachunek w eToro – eToro is the best broker to buy GlaxoSmithKline shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.

Krok 2: Załadować Państwa ID - Zgodnie z przepisami KYC eToro poprosi Państwa o przesłanie kopii paszportu lub prawa jazdy.

Krok 3: Wpłata środków - Proszę wpłacić trochę pieniędzy na swoje nowo utworzone konto eToro. Mogą Państwo wybrać pomiędzy przelewem bankowym, e-wallet lub kartą debetową/kredytową lub Paypal.

Krok 4: Buy GlaxoSmithKline – Search for “”NYSE:GSK”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought GlaxoSmithKline stocks with 0% commission!.

1
logo etoro
Minimalna wpłata
$50
Ekskluzywna promocja
Nasz wynik
10
★★★★★

0% prowizja

Inwestowanie w kryptowaluty jest nieuregulowane w większości krajów UE i w Wielkiej Brytanii. Brak ochrony konsumentów. Państwa kapitał jest narażony na ryzyko. Handel kryptowalutami CFD jest niedostępny dla klientów zamieszkałych w Wielkiej Brytanii i USA.

Is GlaxoSmithKline a buy right now?

13 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for GlaxoSmithKline in the last year. There are currently 4 sell ratings, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.

What stocks does Reportlab like better than GlaxoSmithKline?

Wall Street analysts have given GlaxoSmithKline a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but GlaxoSmithKline wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.

1
logo etoro
Minimalna wpłata
$50
Ekskluzywna promocja
Nasz wynik
10
★★★★★

0% prowizja

2
logo degiro
Minimalna wpłata
$50
Ekskluzywna promocja
Nasz wynik
10
★★★★★

0% prowizja

3
logo freedom finance
Minimalna wpłata
$50
Ekskluzywna promocja
Nasz wynik
10
★★★★★

0% prowizja

CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.

How to buy GlaxoSmithKline stocks step by step guide

It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:GSK stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy GlaxoSmithKline stocks with a step by step approach.

Krok 1: Otwarcie rachunku u brokera

You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy GlaxoSmithKline stocks with 0% comission, to sign up just click on open account in the following table or compare other options.

Krok 2: Zweryfikuj swoje konto

Ponieważ eToro jest platformą regulowaną, musi Pan wypełnić proces KYC, jest to standardowa procedura i zajmuje tylko kilka minut. Musi Pan przedstawić dowód tożsamości ze zdjęciem (paszport, prawo jazdy) oraz dowód adresu (rachunek za media, wyciąg z banku).

Krok 3: Zasilenie konta eToro

Po zarejestrowaniu się i zweryfikowaniu konta, należy wpłacić środki. eToro akceptuje karty kredytowe/debetowe, przelewy bankowe, a także e-wallety. Tak więc niezależnie od Państwa preferencji znajdzie się coś dla Państwa.

Step 4: Search for GlaxoSmithKline stocks

Now that you’ve funded your eToro account, just type “NYSE:GSK stocks" w pasku wyszukiwania na górze ekranu i nacisnąć "handel".

Step 5: Buy NYSE:GSK

All that’s left is to buy some NYSE:GSK stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.

Jak i gdzie kupować akcje Wnioski

All in all, NYSE:GSK is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy GlaxoSmithKline stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.

When is GlaxoSmithKline’s next earnings date?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for GlaxoSmithKline.

How were GlaxoSmithKline’s earnings last quarter?

GlaxoSmithKline plc (NYSE:GSK) released its quarterly earnings data on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by $0.02. The pharmaceutical company had revenue of $8.74 billion for the quarter, compared to the consensus estimate of $8.71 billion. GlaxoSmithKline had a net margin of 18.50% and a trailing twelve-month return on equity of 29.60%. The company’s revenue was down 1.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 earnings per share.
View GlaxoSmithKline’s earnings history.

How has GlaxoSmithKline’s stock been impacted by Coronavirus?

GlaxoSmithKline’s stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GSK shares have decreased by 11.3% and is now trading at $35.38.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline declared a quarterly dividend on Thursday, February 4th. Investors of record on Friday, February 19th will be given a dividend of $0.628 per share on Thursday, April 8th. This represents a $2.51 annualized dividend and a dividend yield of 7.10%. The ex-dividend date is Thursday, February 18th. This is a positive change from GlaxoSmithKline’s previous quarterly dividend of $0.50.
View GlaxoSmithKline’s dividend history.

Where to Buy GlaxoSmithKline Stocks Broker Reviews

Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:GSK stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./

  • eToro szczyci się tym, że dba o bezpieczeństwo swoich klientów, przestrzega ścisłych zasad ochrony danych, aby dostęp do wrażliwych informacji był ograniczony do minimum. Wszystkie informacje, które Państwo podają eToro, są nawet chronione przez szyfrowanie SSL, co gwarantuje, że nawet jeśli ktoś uzyskałby dostęp do serwerów, wszystkie Państwa dane pozostaną bezpieczne.

Ponad 95% środków klientów jest przechowywanych w trybie offline, w zimnym magazynie, co jest kluczowe dla każdego brokera, który zarządza Państwa aktywami. Niezależnie od tego, jak bezpieczna ma być platforma, zalecamy stosowanie 2FA, aby dodać dodatkową warstwę bezpieczeństwa do Państwa konta.

Doskonałe zarówno dla nowych, jak i doświadczonych traderów

eToro oferuje użytkownikom szereg funkcji, aby mogli Państwo jak najszybciej zacząć inwestować. Mają Państwo stosunkowo unikalną funkcję copy trading, która pozwala na uzyskanie pasywnego dochodu poprzez odzwierciedlanie doświadczonych traderów, co pozwala szybko zacząć zarabiać i daje lepsze zrozumienie strategii stosowanych przez profesjonalistów. Dodatkowo eToro umożliwia użytkownikom inwestowanie w zarządzane portfele, przy czym zarządzany portfel to różne podobne aktywa zgrupowane razem, co pozwala na dywersyfikację konta i zmniejsza ewentualne ryzyko. Dla tych, którzy mają już doświadczenie w handlu, mogą Państwo inwestować na rynkach poza akcjami, ponieważ eToro pozwala użytkownikom na handel ETF-ami, towarami, kryptowalutami i indeksami. Jeżeli już inwestują Państwo poza przestrzenią giełdową, może to być bardzo przydatne, ponieważ pozwala to na zarządzanie wszystkimi Państwa inwestycjami w jednym miejscu.

Is GlaxoSmithKline a good dividend stock?

GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.79%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline does not yet have a strock track record of dividend growth. The dividend payout ratio of GlaxoSmithKline is 64.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend.
View GlaxoSmithKline’s dividend history.

Who are GlaxoSmithKline’s key executives?

GlaxoSmithKline’s management team includes the following people:
Ms. Emma N. Walmsley, CEO & Director (Age 51)
Mr. Iain James Mackay, CFO & Exec. Director (Age 59)
Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 58)
Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 60)
Ms. Sarah Elton-Farr, Head of Investor Relations
Mr. Nick Hirons, Sr. VP of Global Ethics & Compliance
Mr. James Ford, Sr. VP & Gen. Counsel
Ms. Sally Jackson, Sr. VP of Global Communications & CEO Office
Ms. Diana Conrad, Sr. VP of HR
Mr. David Simon Redfern, Chief Strategy Officer (Age 55)

Who are some of GlaxoSmithKline’s key competitors?

Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Abbott Laboratories (ABT), Novartis (NVS), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Bayer Aktiengesellschaft (BAYRY) and Vertex Pharmaceuticals (VRTX).
View all of GSK’s competitors.

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from Reportlab watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).

What is GlaxoSmithKline’s stock symbol?

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol “GSK.”

Who are GlaxoSmithKline’s major shareholders?

Who are GlaxoSmithKline’s major shareholders?

1
logo etoro
Minimalna wpłata
$50
Ekskluzywna promocja
Nasz wynik
10
★★★★★

0% prowizja

Inwestowanie w kryptowaluty jest nieuregulowane w większości krajów UE i w Wielkiej Brytanii. Brak ochrony konsumentów. Państwa kapitał jest narażony na ryzyko. Handel kryptowalutami CFD jest niedostępny dla klientów zamieszkałych w Wielkiej Brytanii i USA.

Which institutional investors are selling GlaxoSmithKline stock?

GSK stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, BlackRock Inc., Boston Partners, Aperio Group LLC, Nepsis Inc., Avalon Investment & Advisory, Janney Montgomery Scott LLC, and Chemung Canal Trust Co..
View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks.

Which institutional investors are buying GlaxoSmithKline stock?

GSK stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Fisher Asset Management LLC, Galibier Capital Management Ltd., First Trust Advisors LP, Douglas Lane & Associates LLC, Kestra Advisory Services LLC, Koshinski Asset Management Inc., and Capstone Triton Financial Group LLC.
View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks.

How do I buy shares of GlaxoSmithKline?

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers RevieweToro ReviewPrzegląd DEGiroAvaTrade ReviewIG Markets ReviewIC Markets ReviewCMC Markets ReviewAdmiral Markets Review i wiele innych. Proszę przeczytać jedną z recenzji, aby dowiedzieć się wszystkiego o brokerze i zacząć kupować akcje już teraz.

What is GlaxoSmithKline’s stock price today?

One share of GSK stock can currently be purchased for approximately $35.38.

How much money does GlaxoSmithKline make?

GlaxoSmithKline has a market capitalization of $88.75 billion and generates $43.10 billion in revenue each year. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis.

How many employees does GlaxoSmithKline have?

GlaxoSmithKline employs 99,437 workers across the globe.

Często zadawane pytania

The safest and easiest way to buy NYSE:GSK is by using a regulated broker like eToro. You can open an account with the platform, make a deposit and buy this investment all in under 5 minutes from start to finish.

Inną opcją jest skorzystanie z regulowanej giełdy, jak Binance lub Coinbase. Na tych giełdach mogą Państwo otworzyć konto i zacząć kupować lub handlować. ?

You will first want to find a licensed broker that supports NYSE:GSK stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:GSK stocks in a safe and complete environment.

As with any other asset, there is an element of risk associated with buying NYSE:GSK stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.

 

All stocks are volatile, or affected by market circumstances. The case with NYSE:GSK is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in GlaxoSmithKline stock.

You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for GlaxoSmithKline stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:GSK stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.

To sell your NYSE:GSK stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.

eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:GSK stock.

Podziel się tą informacją
Udostępnij na facebook
Facebook
Udostępnij na twitter
Twitter
Stephen Johnson
Stephen Johnson

Stephen wie wiele o produktach finansowych, a w szczególności pasjonuje się rynkami giełdowymi i ich uczestnikami. Mamy nadzieję, że przedstawione informacje będą dla Państwa pomocne. Coś nie jest całkiem jasne? Proszę zostawić swoje pytania lub komentarze na dole strony.

logo etoro

Nasz wynik
★★★★★

logo degiro

Nasz wynik
★★★★★

logo freedom finance

Nasz wynik
★★★★★

Newsletter

Spis treści

logo etoro

Nasz wynik
★★★★★ 10/10

0% prowizja

CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.

Inne akcje

LogoNazwaTickerNasza rangaWięcej informacjiKup tę monetę
logo etoroChesapeake EnergyCHK

★★★★

Comprar Bitcoin
logo etoroEthereumETH

★★★★★

Comprar Ethereum
logo etoroMoneta BinanceETH

★★★★★

Comprar Binance Coin
logo etoroWięźbaETH

★★★★★

Comprar Bitcoin
logo etoroSolanaETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroXRPETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin
logo etoroCardanoETH

★★★★★

Comprar Bitcoin

Powiązane wiadomości

Zostaw komentarz

Twój adres e-mail nie zostanie opublikowany.

pl_PLPolish